Educational Workshop in Belgrade, Serbia
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Preliminary Program
Activity Approved by
Sponsors
Thank you to our co-hosts
7th Immune Effector Cell Therapies in Multiple Myeloma Workshop
Our sponsors:
Titanium
Platinum
Gold
Silver
NDMM and RRMM Webinar – East Coast
This high-impact, 90-minute educational program will focus on the latest evidence for optimizing treatments for Newly Diagnosed and Relapsed/Refractory patients, including choices for immunotherapy. Key concepts will be covered in presentations by senior faculty, along with practice-relevant case-based discussions.
NDMM and RRMM Webinar – West Coast
This high-impact, 90-minute educational program will focus on the latest evidence for optimizing treatments for Newly Diagnosed and Relapsed/Refractory patients, including choices for immunotherapy. Key concepts will be covered in presentations by senior faculty, along with practice-relevant case-based discussions.
4th Annual Workshop on Genomics
IMS is pleased to announce that the 4th Annual Workshop on Genomics will take place from July 10-11, 2026 in Warsaw, Poland.
More details will be available soon!
23rd Annual Meeting & Exposition
Mark your calendars for the 23rd IMS Annual Meeting in Glasgow, Scotland.
The International Myeloma Society Annual Meeting is the defining annual meeting in myeloma.
More details on the program, abstract submissions, registration and housing will be available soon.
Our sponsors:
Titanium
Platinum
Silver
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
